In addition to the exposure of the terminal GalNAc residue, the binding of MGL in ovarian cancer cells is influenced by other factors, such as glycopeptide conformation and glycan arrangement along the peptide backbone. The gene discussed is CLEC10A; the disease is ovarian cancer.